United States Pharmaceuticals

Teligent Inc (NEW JERSEY) (TLGT)

Track

Stock chart
Ticker: TLGT Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Pate R Carter
1 purchase — total 16,491 USD
Buy 27 May 2021
Value US$222,341.98 | Price 110.87 | Shares 97,030
Sale 26 Aug 2020
Value US$2,841,840.19 | Price 337.30 | Shares 72,319
Sale 26 Aug 2020
Value US$2,700,504.81 | Price 291.66 | Shares 28,731
Sale 25 Aug 2020
Value US$17,106.29 | Price 1.13 | Shares 15,184
Sale 25 Aug 2020
Value US$96,147.42 | Price 1.13 | Shares 84,816
Sale 21 Aug 2020
Value US$30,539.98 | Price 1.66 | Shares 18,432
Sale 21 Aug 2020
Value US$171,071.36 | Price 1.66 | Shares 102,962
Sale 19 Aug 2020
Value US$29,760.42 | Price 2.25 | Shares 13,251
Sale 19 Aug 2020
Value US$167,026.13 | Price 2.26 | Shares 74,020
Buy 3 Jun 2019
Value US$7,005.00 | Price 0.70 | Shares 10,000
Buy 31 May 2019
Value US$16,520.00 | Price 0.66 | Shares 25,000
Buy 31 May 2019
Value US$12,904.00 | Price 0.65 | Shares 20,000
Buy 31 May 2019
Value US$13,166.00 | Price 0.66 | Shares 20,000
Buy 30 May 2019
Value US$5,885.00 | Price 0.59 | Shares 10,000
Buy 23 May 2019
Value US$17,335.00 | Price 0.69 | Shares 25,000
Buy 23 May 2019
Value US$13,814.00 | Price 0.69 | Shares 20,000
Buy 14 Dec 2018
Value US$18,200.00 | Price 1.82 | Shares 10,000
Buy 14 Dec 2018
Value US$21,372.00 | Price 1.78 | Shares 12,000
Planned sale 4 Sep 2018
Value US$400.50 | Price 4.01 | Shares 100
Planned sale 4 Sep 2018
Value US$210,800.00 | Price 4.00 | Shares 52,700
Buy 13 Nov 2017
Value US$12,538.80 | Price 3.48 | Shares 3,600
Buy 13 Nov 2017
Value US$4,869.76 | Price 3.48 | Shares 1,400
Buy 10 Nov 2017
Value US$1,084.02 | Price 3.61 | Shares 300
Buy 10 Nov 2017
Value US$10,490.46 | Price 3.62 | Shares 2,900
Buy 10 Nov 2017
Value US$6,513.84 | Price 3.62 | Shares 1,800
Buy 10 Nov 2017
Value US$57,136.50 | Price 3.81 | Shares 15,000
Buy 9 Nov 2017
Value US$20,055.61 | Price 3.13 | Shares 6,410
Buy 8 Nov 2017
Value US$21,280.00 | Price 3.04 | Shares 7,000
Buy 11 Mar 2016
Value US$73,717.50 | Price 4.91 | Shares 15,000
Buy 11 Mar 2016
Value US$50,628.90 | Price 4.82 | Shares 10,500
Buy 30 Apr 2015
Value US$50,400.00 | Price 5.04 | Shares 10,000
Buy 30 Apr 2015
Value US$100,800.00 | Price 5.04 | Shares 20,000
Sale 5 Mar 2015
Value US$16,878,384.00 | Price 9.95 | Shares 1,696,320
Sale 5 Mar 2015
Value US$3,021,616.00 | Price 9.95 | Shares 303,680
Sale 2 Sep 2014
Value US$10,942,425.00 | Price 6.45 | Shares 1,696,500
Sale 2 Sep 2014
Value US$1,957,575.00 | Price 6.45 | Shares 303,500
Sale 27 Aug 2014
Value US$15,777,406.60 | Price 6.20 | Shares 2,544,743
Sale 27 Aug 2014
Value US$2,822,593.40 | Price 6.20 | Shares 455,257
Buy 22 Aug 2014
Value US$29,500.00 | Price 5.90 | Shares 5,000
Sale 9 Jun 2014
Value US$95,900.00 | Price 5.48 | Shares 17,500
Buy 6 Aug 2013
Value US$17,304.32 | Price 1.45 | Shares 11,902
Buy 5 Aug 2013
Value US$5,919.20 | Price 1.48 | Shares 4,000
Buy 2 Aug 2013
Value US$14,794.00 | Price 1.48 | Shares 10,000
Buy 30 Jul 2013
Value US$6,671.84 | Price 1.48 | Shares 4,508
Buy 26 Jul 2013
Value US$29,189.10 | Price 1.49 | Shares 19,590
Buy 24 May 2013
Value US$5,425.00 | Price 1.55 | Shares 3,500
Buy 13 Mar 2013
Value US$13,265.00 | Price 1.33 | Shares 10,000
Buy 13 Mar 2013
Value US$6,647.00 | Price 1.33 | Shares 5,000
Buy 12 Mar 2013
Value US$2,814.00 | Price 1.34 | Shares 2,100
Buy 12 Mar 2013
Value US$1,201.50 | Price 1.34 | Shares 900
Buy 12 Mar 2013
Value US$16,280.00 | Price 1.30 | Shares 12,500
Buy 11 Mar 2013
Value US$3,630.00 | Price 1.21 | Shares 3,000
Buy 11 Mar 2013
Value US$552.24 | Price 1.18 | Shares 468
Buy 8 Mar 2013
Value US$1,807.76 | Price 1.18 | Shares 1,532
Buy 7 Mar 2013
Value US$8,784.85 | Price 1.15 | Shares 7,639
Buy 6 Mar 2013
Value US$5,697.72 | Price 1.14 | Shares 4,998
Buy 14 Aug 2012
Value US$11,500.00 | Price 1.15 | Shares 10,000
Sale 23 May 2012
Value US$6,650.00 | Price 0.95 | Shares 7,000
Sale 22 May 2012
Value US$9,500.00 | Price 0.95 | Shares 10,000
Sale 21 May 2012
Value US$907.00 | Price 1.00 | Shares 907
Sale 18 May 2012
Value US$843.00 | Price 1.00 | Shares 843
Sale 17 May 2012
Value US$306.00 | Price 1.02 | Shares 300
Sale 16 May 2012
Value US$608.00 | Price 1.00 | Shares 608
Sale 15 May 2012
Value US$1,485.00 | Price 1.00 | Shares 1,485
Sale 11 May 2012
Value US$15.75 | Price 1.05 | Shares 15
Sale 19 Mar 2012
Value US$9,775.00 | Price 1.15 | Shares 8,500
Sale 1 Mar 2012
Value US$5,600.50 | Price 1.15 | Shares 4,870
Sale 28 Feb 2012
Value US$149.50 | Price 1.15 | Shares 130
Sale 11 May 2011
Value US$29,750.00 | Price 1.19 | Shares 25,000
Sale 27 Jan 2011
Value US$8,750.00 | Price 1.75 | Shares 5,000
Sale 16 Nov 2010
Value US$8,000.00 | Price 1.60 | Shares 5,000
Buy 10 Aug 2010
Value US$768.00 | Price 1.28 | Shares 600
Buy 10 Aug 2010
Value US$650.00 | Price 1.30 | Shares 500
Buy 9 Aug 2010
Value US$1,210.00 | Price 1.21 | Shares 1,000
Buy 9 Aug 2010
Value US$248.00 | Price 1.24 | Shares 200
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-05-27 2021-05-27 B Purchase
2.8
Pate R Carter
Non-Executive Director
97,030 -2.6%
110.87
US$222,342 		97,030 -2.6% 110.87 US$222,342
2020-09-16 2020-08-26 S Sale
LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP
Non-Executive Director Large shareholder
72,319 +46.0%
337.30
US$2,841,840 		72,319 +46.0% 337.30 US$2,841,840
2020-09-16 2020-08-26 S Sale
LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP
Non-Executive Director Large shareholder
28,731 -12.0%
291.66
US$2,700,505 		28,731 -12.0% 291.66 US$2,700,505
2020-09-16 2020-08-25 S Sale
LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP
Non-Executive Director Large shareholder
15,184 -12.9%
1.13
US$17,106 		15,184 -12.9% 1.13 US$17,106
2020-09-16 2020-08-25 S Sale
LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP
Non-Executive Director Large shareholder
84,816 -12.9%
1.13
US$96,147 		84,816 -12.9% 1.13 US$96,147
2020-09-16 2020-08-21 S Sale
LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP
Non-Executive Director Large shareholder
18,432 -13.5%
1.66
US$30,540 		18,432 -13.5% 1.66 US$30,540
2020-09-16 2020-08-21 S Sale
LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP
Non-Executive Director Large shareholder
102,962 -13.5%
1.66
US$171,071 		102,962 -13.5% 1.66 US$171,071
2020-09-16 2020-08-19 S Sale
LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP
Non-Executive Director Large shareholder
13,251 -8.9%
2.25
US$29,760 		13,251 -8.9% 2.25 US$29,760
2020-09-16 2020-08-19 S Sale
LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP
Non-Executive Director Large shareholder
74,020 -8.9%
2.26
US$167,026 		74,020 -8.9% 2.26 US$167,026
2019-06-04 2019-06-03 B Purchase
CHAUDHURI BHASKAR
10,000 +inf%
0.70
US$7,005 		10,000 +inf% 0.70 US$7,005
2019-06-03 2019-05-31 B Purchase
SABATINO THOMAS J JR
25,000 +inf%
0.66
US$16,520 		25,000 +inf% 0.66 US$16,520
2019-05-31 2019-05-31 B Purchase
Celentano John E
Non-Executive Director
20,000 +inf%
0.65
US$12,904 		20,000 +inf% 0.65 US$12,904
2019-05-31 2019-05-31 B Purchase
GALE JAMES C
Non-Executive Director
20,000 +5.3%
0.66
US$13,166 		20,000 +5.3% 0.66 US$13,166
2019-05-31 2019-05-30 B Purchase
3.5
BEN-MAIMON CAROLE
10,000 +166.7%
0.59
US$5,885 		10,000 +166.7% 0.59 US$5,885
2019-05-24 2019-05-23 B Purchase
Grenfell-Gardner Jason

President & CEO

Executive Director
25,000 +26.4%
0.69
US$17,335 		25,000 +26.4% 0.69 US$17,335
2019-05-24 2019-05-23 B Purchase
GALE JAMES C
Non-Executive Director
20,000 +5.6%
0.69
US$13,814 		20,000 +5.6% 0.69 US$13,814
2018-12-14 2018-12-14 B Purchase Finio Damian

CFO

Officer
10,000 +inf%
1.82
US$18,200 		10,000 +inf% 1.82 US$18,200
2018-12-14 2018-12-14 B Purchase Richardson Stephen

Chief Scientific Officer

Officer
12,000 +30.6%
1.78
US$21,372 		12,000 +30.6% 1.78 US$21,372
2018-09-05 2018-09-04 PlS Planned sale Grenfell-Gardner Jason

President & CEO

Executive Director
100 -0.1%
4.01
US$400 		100 -0.1% 4.01 US$400
2018-09-05 2018-09-04 PlS Planned sale Grenfell-Gardner Jason

President & CEO

Executive Director
52,700 -35.7%
4.00
US$210,800 		52,700 -35.7% 4.00 US$210,800
2017-11-13 2017-11-13 B Purchase BEN-MAIMON CAROLE
3,600 +150.0%
3.48
US$12,539 		3,600 +150.0% 3.48 US$12,539
2017-11-13 2017-11-13 B Purchase BEN-MAIMON CAROLE
1,400 +140.0%
3.48
US$4,870 		1,400 +140.0% 3.48 US$4,870
2017-11-13 2017-11-10 B Purchase KOEHLER STEVEN H
300 +6.4%
3.61
US$1,084 		300 +6.4% 3.61 US$1,084
2017-11-13 2017-11-10 B Purchase KOEHLER STEVEN H
2,900 +161.1%
3.62
US$10,490 		2,900 +161.1% 3.62 US$10,490
2017-11-13 2017-11-10 B Purchase KOEHLER STEVEN H
1,800 +inf%
3.62
US$6,514 		1,800 +inf% 3.62 US$6,514
2017-11-13 2017-11-10 B Purchase GALE JAMES C
15,000 +4.4%
3.81
US$57,136 		15,000 +4.4% 3.81 US$57,136
2017-11-13 2017-11-09 B Purchase Richardson Stephen

Chief Scientific Officer
6,410 +76.9%
3.13
US$20,056 		6,410 +76.9% 3.13 US$20,056
2017-11-09 2017-11-08 B Purchase Collins Jenniffer

CFO
7,000 +57.3%
3.04
US$21,280 		7,000 +57.3% 3.04 US$21,280
2016-03-14 2016-03-11 B Purchase GALE JAMES C Non-Executive Director Large shareholder
15,000 +150.0%
4.91
US$73,718 		15,000 +150.0% 4.91 US$73,718
2016-03-14 2016-03-11 B Purchase Grenfell-Gardner Jason

President & CEO

Executive Director
10,500 +4.4%
4.82
US$50,629 		10,500 +4.4% 4.82 US$50,629
2015-05-01 2015-04-30 B Purchase GALE JAMES C Non-Executive Director Large shareholder
10,000 +25.2%
5.04
US$50,400 		10,000 +25.2% 5.04 US$50,400
2015-05-01 2015-04-30 B Purchase GALE JAMES C Non-Executive Director Large shareholder
20,000 +101.9%
5.04
US$100,800 		20,000 +101.9% 5.04 US$100,800
2015-03-06 2015-03-05 S Sale LIFE SCIENCES OPPORTUNITIES FUND II LP Large shareholder
1,696,320 -16.9%
9.95
US$16,878,384 		1,696,320 -16.9% 9.95 US$16,878,384
2015-03-06 2015-03-05 S Sale LIFE SCIENCES OPPORTUNITIES FUND II LP Large shareholder
303,680 -16.9%
9.95
US$3,021,616 		303,680 -16.9% 9.95 US$3,021,616
2014-09-04 2014-09-02 S Sale LIFE SCIENCES OPPORTUNITIES FUND II LP

See Remarks

Large shareholder
1,696,500 -14.4%
6.45
US$10,942,425 		1,696,500 -14.4% 6.45 US$10,942,425
2014-09-04 2014-09-02 S Sale LIFE SCIENCES OPPORTUNITIES FUND II LP

See Remarks

Large shareholder
303,500 -14.4%
6.45
US$1,957,575 		303,500 -14.4% 6.45 US$1,957,575
2014-08-29 2014-08-27 S Sale LIFE SCIENCES OPPORTUNITIES FUND II LP

See Remarks

Large shareholder
2,544,743 -17.8%
6.20
US$15,777,407 		2,544,743 -17.8% 6.20 US$15,777,407
2014-08-29 2014-08-27 S Sale LIFE SCIENCES OPPORTUNITIES FUND II LP

See Remarks

Large shareholder
455,257 -17.8%
6.20
US$2,822,593 		455,257 -17.8% 6.20 US$2,822,593
2014-08-26 2014-08-22 B Purchase GALE JAMES C Non-Executive Director Large shareholder
5,000 +34.2%
5.90
US$29,500 		5,000 +34.2% 5.90 US$29,500
2014-06-11 2014-06-09 S Sale Erony Joyce Non-Executive Director
17,500 -76.6%
5.48
US$95,900 		17,500 -76.6% 5.48 US$95,900
2013-08-07 2013-08-06 B Purchase Hemric Michael B. Non-Executive Director
11,902 +19.3%
1.45
US$17,304 		11,902 +19.3% 1.45 US$17,304
2013-08-07 2013-08-05 B Purchase Hemric Michael B. Non-Executive Director
4,000 +6.9%
1.48
US$5,919 		4,000 +6.9% 1.48 US$5,919
2013-08-07 2013-08-02 B Purchase Hemric Michael B. Non-Executive Director
10,000 +21.0%
1.48
US$14,794 		10,000 +21.0% 1.48 US$14,794
2013-08-07 2013-07-30 B Purchase Hemric Michael B. Non-Executive Director
4,508 +10.5%
1.48
US$6,672 		4,508 +10.5% 1.48 US$6,672
2013-08-07 2013-07-26 B Purchase Hemric Michael B. Non-Executive Director
19,590 +83.3%
1.49
US$29,189 		19,590 +83.3% 1.49 US$29,189
2013-05-29 2013-05-24 B Purchase Grenfell-Gardner Jason

President & CEO

Executive Director
3,500 +35.0%
1.55
US$5,425 		3,500 +35.0% 1.55 US$5,425
2013-03-15 2013-03-13 B Purchase GALE JAMES C Non-Executive Director Large shareholder
10,000 +216.3%
1.33
US$13,265 		10,000 +216.3% 1.33 US$13,265
2013-03-14 2013-03-13 B Purchase Erony Joyce Non-Executive Director Large shareholder
5,000 +28.0%
1.33
US$6,647 		5,000 +28.0% 1.33 US$6,647
2013-03-14 2013-03-12 B Purchase Hemric Michael B. Non-Executive Director
2,100 +9.8%
1.34
US$2,814 		2,100 +9.8% 1.34 US$2,814
2013-03-14 2013-03-12 B Purchase Hemric Michael B. Non-Executive Director
900 +4.4%
1.34
US$1,202 		900 +4.4% 1.34 US$1,202
2013-03-14 2013-03-12 B Purchase Erony Joyce Non-Executive Director Large shareholder
12,500 +233.7%
1.30
US$16,280 		12,500 +233.7% 1.30 US$16,280
2013-03-14 2013-03-11 B Purchase Hemric Michael B. Non-Executive Director
3,000 +17.1%
1.21
US$3,630 		3,000 +17.1% 1.21 US$3,630
2013-03-14 2013-03-11 B Purchase Hemric Michael B. Non-Executive Director
468 +2.7%
1.18
US$552 		468 +2.7% 1.18 US$552
2013-03-14 2013-03-08 B Purchase Hemric Michael B. Non-Executive Director
1,532 +9.9%
1.18
US$1,808 		1,532 +9.9% 1.18 US$1,808
2013-03-14 2013-03-07 B Purchase Hemric Michael B. Non-Executive Director
7,639 +96.9%
1.15
US$8,785 		7,639 +96.9% 1.15 US$8,785
2013-03-14 2013-03-06 B Purchase Hemric Michael B. Non-Executive Director
4,998 +173.2%
1.14
US$5,698 		4,998 +173.2% 1.14 US$5,698
2012-08-16 2012-08-14 B Purchase Grenfell-Gardner Jason

President & CEO

Executive Director
10,000 +inf%
1.15
US$11,500 		10,000 +inf% 1.15 US$11,500
2012-05-30 2012-05-23 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
7,000 -30.5%
0.95
US$6,650 		7,000 -30.5% 0.95 US$6,650
2012-05-30 2012-05-22 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
10,000 -38.6%
0.95
US$9,500 		10,000 -38.6% 0.95 US$9,500
2012-05-30 2012-05-21 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
907 -5.4%
1.00
US$907 		907 -5.4% 1.00 US$907
2012-05-30 2012-05-18 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
843 -5.0%
1.00
US$843 		843 -5.0% 1.00 US$843
2012-05-30 2012-05-17 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
300 -1.8%
1.02
US$306 		300 -1.8% 1.02 US$306
2012-05-30 2012-05-16 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
608 -3.7%
1.00
US$608 		608 -3.7% 1.00 US$608
2012-05-30 2012-05-15 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
1,485 -8.5%
1.00
US$1,485 		1,485 -8.5% 1.00 US$1,485
2012-05-30 2012-05-11 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
15 -0.1%
1.05
US$16 		15 -0.1% 1.05 US$16
2012-03-23 2012-03-19 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
8,500 -34.8%
1.15
US$9,775 		8,500 -34.8% 1.15 US$9,775
2012-03-07 2012-03-01 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
4,870 -23.4%
1.15
US$5,600 		4,870 -23.4% 1.15 US$5,600
2012-03-07 2012-02-28 S Sale Lawrence Nadya

Exec. VP-Sales & Marketing

Officer
130 -0.8%
1.15
US$150 		130 -0.8% 1.15 US$150
2011-05-13 2011-05-11 S Sale Lawrence Nadya

Exec. VP-Sales and Marketing

Officer
25,000 -61.1%
1.19
US$29,750 		25,000 -61.1% 1.19 US$29,750
2011-02-04 2011-01-27 S Sale Lawrence Nadya

Exec. VP-Sales and Marketing

Officer
5,000 -31.4%
1.75
US$8,750 		5,000 -31.4% 1.75 US$8,750
2010-12-08 2010-11-16 S Sale Lawrence Nadya

Exec. VP-Sales and Marketing

Officer
5,000 -31.4%
1.60
US$8,000 		5,000 -31.4% 1.60 US$8,000
2010-08-11 2010-08-10 B Purchase GERARDI FRANK Large shareholder
600 +0.0%
1.28
US$768 		600 +0.0% 1.28 US$768
2010-08-11 2010-08-10 B Purchase GERARDI FRANK Large shareholder
500 +0.0%
1.30
US$650 		500 +0.0% 1.30 US$650
2010-08-11 2010-08-09 B Purchase GERARDI FRANK Large shareholder
1,000 +0.0%
1.21
US$1,210 		1,000 +0.0% 1.21 US$1,210
2010-08-11 2010-08-09 B Purchase GERARDI FRANK Large shareholder
200 +0.0%
1.24
US$248 		200 +0.0% 1.24 US$248
Explore more

More insider trading research around Teligent Inc (NEW JERSEY)

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America